SMTL ID : 5h24.1 (1 other biounit)

EED in complex with PRC2 allosteric inhibitor compound 8

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

hetero-1-1-mer

Ligands

1 x LQG: 5-(furan-2-ylmethylamino)-[1,2,4]triazolo[4,3-a]pyridine-6-carbonitrile(Non-covalent)

LQG.1: 8 residues within 4Å: Chain A: F.23, Y.74, N.120, K.137, L.166, D.236, Y.291, R.293 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:N.120, A:L.166, A:Y.291 Hydrogen bonds: A:N.120, A:K.137, A:R.293 Water bridges: A:Y.74 pi-Stacking: A:F.23, A:Y.74, A:Y.74, A:Y.291, A:Y.291, A:Y.291

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Huang, Y. et al., Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy. J. Med. Chem. (2017)

Release Date

2017-01-25

Peptides

Polycomb protein EED: A
Histone-lysine N-methyltransferase EZH2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

Polycomb protein EED

Histone-lysine N-methyltransferase EZH2

Related Entries With Identical Sequence